Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1959 2
1960 1
1961 2
1963 1
1965 1
1966 3
1967 2
1968 5
1969 2
1970 8
1971 3
1972 1
1973 1
1974 6
1975 6
1976 9
1977 12
1978 4
1979 9
1980 4
1981 11
1982 14
1983 14
1984 8
1985 6
1986 9
1987 14
1988 15
1989 22
1990 19
1991 11
1992 10
1993 16
1994 12
1995 23
1996 20
1997 24
1998 17
1999 21
2000 20
2001 23
2002 25
2003 24
2004 25
2005 16
2006 12
2007 14
2008 20
2009 26
2010 35
2011 33
2012 36
2013 43
2014 50
2015 55
2016 69
2017 68
2018 75
2019 71
2020 92
2021 105
2022 91
2023 76

Text availability

Article attribute

Article type

Publication date

Search Results

1,365 results

Results by year

Filters applied: . Clear all
Page 1
Involvement of Parkin-mediated mitophagy in the pathogenesis of chronic obstructive pulmonary disease-related sarcopenia.
Ito A, Hashimoto M, Tanihata J, Matsubayashi S, Sasaki R, Fujimoto S, Kawamoto H, Hosaka Y, Ichikawa A, Kadota T, Fujita Y, Takekoshi D, Ito S, Minagawa S, Numata T, Hara H, Matsuoka T, Udaka J, Araya J, Saito M, Kuwano K. Ito A, et al. Among authors: sasaki r. J Cachexia Sarcopenia Muscle. 2022 Jun;13(3):1864-1882. doi: 10.1002/jcsm.12988. Epub 2022 Apr 3. J Cachexia Sarcopenia Muscle. 2022. PMID: 35373498 Free PMC article.
Effect of exercise and/or educational interventions on physical activity and pain in patients with hip/knee osteoarthritis: A systematic review with meta-analysis.
Sasaki R, Honda Y, Oga S, Fukushima T, Tanaka N, Kajiwara Y, Nakagawa K, Takahashi A, Sakamoto Y, Morita H, Kondo Y, Okita S, Kondo Y, Goto K, Kataoka H, Sakamoto J, Okita M. Sasaki R, et al. PLoS One. 2022 Nov 21;17(11):e0275591. doi: 10.1371/journal.pone.0275591. eCollection 2022. PLoS One. 2022. PMID: 36409668 Free PMC article.
Effects of Physical-Agent Pain Relief Modalities for Fibromyalgia Patients: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Honda Y, Sakamoto J, Hamaue Y, Kataoka H, Kondo Y, Sasabe R, Goto K, Fukushima T, Oga S, Sasaki R, Tanaka N, Nakano J, Okita M. Honda Y, et al. Among authors: sasaki r. Pain Res Manag. 2018 Oct 1;2018:2930632. doi: 10.1155/2018/2930632. eCollection 2018. Pain Res Manag. 2018. PMID: 30402199 Free PMC article. Review.
Gingival amalgam tattoo.
Sasaki R, Taneda S, Okamoto T. Sasaki R, et al. CMAJ. 2023 Aug 21;195(32):E1083-E1084. doi: 10.1503/cmaj.230584. CMAJ. 2023. PMID: 37604524 Free PMC article. No abstract available.
Unusual Natal Tooth.
Sasaki R, Matsumine M. Sasaki R, et al. Plast Reconstr Surg Glob Open. 2018 Aug 8;6(8):e1891. doi: 10.1097/GOX.0000000000001891. eCollection 2018 Aug. Plast Reconstr Surg Glob Open. 2018. PMID: 30324070 Free PMC article. No abstract available.
Genial Tubercle Fracture.
Sasaki R, Okamoto T, Sangu N, Watanabe Y, Ando T. Sasaki R, et al. J Craniofac Surg. 2019 Jan;30(1):161-162. doi: 10.1097/SCS.0000000000004804. J Craniofac Surg. 2019. PMID: 30339593
Tau Filaments from Amyotrophic Lateral Sclerosis/Parkinsonism-Dementia Complex (ALS/PDC) adopt the CTE Fold.
Qi C, Verheijen BM, Kokubo Y, Shi Y, Tetter S, Murzin AG, Nakahara A, Morimoto S, Vermulst M, Sasaki R, Aronica E, Hirokawa Y, Oyanagi K, Kakita A, Ryskeldi-Falcon B, Yoshida M, Hasegawa M, Scheres SHW, Goedert M. Qi C, et al. Among authors: sasaki r. bioRxiv. 2023 Apr 28:2023.04.26.538417. doi: 10.1101/2023.04.26.538417. Preprint. bioRxiv. 2023. PMID: 37162924 Free PMC article.
Comparison of Efficacy and Safety of Atezolizumab Plus Bevacizumab and Lenvatinib as First-Line Therapy for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis.
Niizeki T, Tokunaga T, Takami Y, Wada Y, Harada M, Shibata M, Nakao K, Sasaki R, Hirai F, Shakado S, Yoshizumi T, Itoh S, Yatsuhashi H, Bekki S, Ido A, Mawatari S, Honda K, Sugimoto R, Senju T, Takahashi H, Kuwashiro T, Maeshiro T, Nakamuta M, Aratake Y, Yamashita T, Otsuka Y, Matsumoto S, Sohda T, Shimose S, Murotani K, Tanaka Y. Niizeki T, et al. Among authors: sasaki r. Target Oncol. 2022 Nov;17(6):643-653. doi: 10.1007/s11523-022-00921-x. Epub 2022 Oct 22. Target Oncol. 2022. PMID: 36272060 Free PMC article.
1,365 results